Abstract: Use of a fungal biomass for treating industrial wastewaters containing at least one dye, wherein: i. the fungal biomass contains at least the fungal species Cunninghamella elegans Lendner; ii. the fungal biomass absorbs the at least one dye, so as to obtain wastewater that is basically free of the at least one dye.

Abstract: The present invention concerns peptide sequences that specifically recognize cells of human hepatic metastases. The invention comprises also the use of nucleic acids coding for such peptides, as well as conjugates and formulations of such peptides for diagnostic and therapeutic purposes.

Abstract: The present invention relates to luminescent compounds having a functionalised linker arm, their synthesis and use in bioconjugation and labelling of biomolecules, such as for example nucleosides, nucleotides, nucleic acids (DNA, RNA or PNA) and proteins, as well as their use in the execution of in vitro and in vivo analytic and diagnostic assays.

Abstract: The invention refers to the in vitro and in vivo use of parasympatholytic substances, preferably scopolamine, to potentiate and accelerate the differentiation of stem cells into cells with a tissue-specific phenotype, and the process and compositions related thereto.

Abstract: The present invention concerns peptide sequences that specifically recognize cells of human hepatic metastases. The invention comprises also the use of nucleic acids coding for such peptides, as well as conjugates and formulations of such peptides for diagnostic and therapeutic purposes.

Abstract: Use of a fungal biomass for treating industrial wastewaters containing at least one dye, wherein: i. the fungal biomass contains at least the fungal species Rhizopus stolonifer (Ehrenberg) Vuillemin; ii. the fungal biomass absorbs the at least one dye, so as to obtain wastewater that is basically free of the at least one dye.

Abstract: It is generally accepted that salivary components are important for dental health, but till now no clear correlation has been found between one or more of said components and the onset of dental caries. The present invention relates to an assay method comprising analysing the presence and/or the content of the salivary soluble CD14 protein from a saliva sample of the individual subjected to examination; the absence of said protein from the salivary sample, or its presence in a reduced amount compared to a predetermined threshold value in caries-free individuals, is considered as a marker of susceptibility to developing caries and/or as a diagnostic element for the existence of ongoing carious lesions.

Abstract: Use of a fungal biomass for treating industrial wastewaters containing at least one dye, wherein: i. the fungal biomass contains at least the fungal species Rhizopus stolonifer (Ehrenberg) Vuillemin; ii. the fungal biomass absorbs the at least one dye, so as to obtain wastewater that is basically free of the at least one dye.

Abstract: Use of a fungal biomass for treating industrial wastewaters containing at least one dye and related method, wherein: i. the fungal biomass contains at least the fungal species Rhizomucor pusillus (Lindt) Schipper; ii. the fungal biomass absorbs the at least one dye, so as to obtain wastewater that is basically free of the at least one dye.